Tim Moseley

The Filer, MPX Bioceutical ULC, applied for an order to cease to be a reporting issuer in all jurisdictions of Canada where it is a reporting issuer.

The Filer was formed through an amalgamation pursuant to a plan of arrangement, after which its outstanding securities were exchanged or assumed by iAnthus Capital Holdings, Inc. The Filer's shares were delisted from the CSE and OTCQX.

The Ontario Securities Commission granted the order, finding that the Filer met the test under the securities legislation to cease being a reporting issuer.

Ninepoint Partners LP applied for exemptive relief on behalf of certain investment funds to permit a fund-on-fund structure.

The requested relief would exempt the funds from restrictions prohibiting them from investing in other funds where they would become a substantial securityholder, and from related reporting obligations.

The Ontario Securities Commission granted the relief, subject to several conditions including that the investments are consistent with the top funds' objectives, effected at an objective price, and that no duplicative fees are charged.

Portage Biotech Inc. applied to the Ontario Securities Commission for an exemption from the prospectus requirement under section 53 of the Securities Act.

The applicant proposed to distribute shares of Biohaven Pharmaceutical Holding Company Ltd. to its Canadian shareholders by way of a dividend in specie.

The Commission granted the requested exemption, provided that the first trade in the acquired shares is deemed a distribution unless specific conditions under National Instrument 45-102 are met.

The Filers applied to the Ontario Securities Commission for an exemption from the prospectus requirement in respect of the distribution of contracts for difference and other over-the-counter foreign exchange contracts to investors in Canada.

The Commission granted the requested relief, subject to conditions including that the Canadian Filer remain registered as an investment dealer, comply with IIROC rules, and provide clients with a comprehensive risk disclosure document prior to trading.

The Filers applied for exemptive relief from the dealer and adviser registration requirements and the prospectus requirement in connection with their Note Program, which funds mortgage loans for charitable purposes within the Pentecostal community.

The Ontario Securities Commission granted interim registration and prospectus exemptions to allow the Filers to transition to the modernized regulatory regime, as well as an ongoing prospectus exemption similar to the offering memorandum exemption, subject to specific terms and conditions including investment limits and investor protection measures.

Sanofi applied to the Ontario Securities Commission for exemptive relief from the prospectus and dealer registration requirements in connection with a global employee share offering.

The offering involved the issuance of units in a temporary French collective shareholding vehicle (FCPE) to Canadian employees, which would later merge with a principal FCPE.

The Commission granted the requested relief, subject to conditions regarding the first trade of the securities and the issuer's non-reporting status in Canada.

The applicant, Niagara Ventures Corporation, applied to the Ontario Securities Commission for an order to cease being a reporting issuer in all applicable Canadian jurisdictions.

Following a going-private transaction by way of a share consolidation, the applicant's outstanding securities became beneficially owned by a single securityholder, and its common shares were delisted from the TSX Venture Exchange.

The Commission granted the requested order.

Sprott Asset Management LP applied for exemptive relief on behalf of certain top funds to permit them to invest in underlying funds such that they become substantial security holders.

The Ontario Securities Commission granted the requested relief, subject to conditions including that the top funds are distributed solely pursuant to prospectus exemptions, the investments are compatible with the top funds' objectives, and there is no duplication of management or incentive fees.

The applicant, a U.S.-based manufacturing company listed on the NYSE, applied for a decision that it is no longer a reporting issuer in British Columbia, Ontario, and Nova Scotia.

The applicant has no operations in Canada and a minimal number of Canadian securityholders.

The Ontario Securities Commission, acting as principal regulator, granted the requested exemptive relief, noting the applicant's undertaking to continue delivering U.S. continuous disclosure materials to its Canadian securityholders.

The applicant, an investment dealer, applied to the Ontario Securities Commission for an exemption from the prospectus requirement for the distribution of contracts for difference (CFDs) and over-the-counter foreign exchange contracts to investors in applicable jurisdictions.

The Commission granted the requested relief, subject to conditions including that the applicant remain registered as an investment dealer, comply with IIROC rules, and provide clients with a clear risk disclosure document prior to trading.

The applicant sought exemptive relief from the prospectus and dealer registration requirements of Ontario securities legislation in connection with a global employee share offering.

The offering involved the issuance of units in a French collective shareholding vehicle to Canadian employees.

The Ontario Securities Commission granted the requested relief, subject to conditions regarding the first trade of the securities.

The applicant, Aon Hewitt Investment Management Inc., applied on behalf of several mutual funds for exemptive relief from the investment restrictions in the securities legislation that prohibit an investment fund from knowingly making an investment in a person or company in which the investment fund is a substantial securityholder.

The Ontario Securities Commission granted the requested relief, subject to conditions including that the securities of the Top Funds are distributed solely pursuant to prospectus exemptions, the investments are compatible with the Top Funds' objectives, and there is no duplication of management or incentive fees.

The Filer, Computer Sciences Corporation, applied to the Ontario Securities Commission for an exemption from the prospectus requirement under section 53 of the Securities Act.

The exemption was sought in connection with a proposed spin-off of its subsidiary, CSGS, by way of a dividend in specie to Canadian shareholders.

The Commission granted the exemption, noting that the number of Canadian shareholders was de minimis and that they would receive the same disclosure materials as United States shareholders.

The first trade in the distributed shares will be deemed a distribution unless certain resale conditions are met.

The Filer applied for a decision under the securities legislation of Ontario to be exempt from the prospectus requirement in respect of the distribution of contracts for difference and over-the-counter foreign exchange contracts to investors resident in the Applicable Jurisdictions.

The Ontario Securities Commission granted the requested relief, subject to terms and conditions, including that the Filer remains registered as an investment dealer and a member of IIROC, and complies with IIROC rules and acceptable practices.

Catamaran Corporation applied for a decision under the securities legislation of multiple Canadian jurisdictions that it is no longer a reporting issuer.

Following a statutory plan of arrangement, the Filer became a wholly-owned subsidiary of UnitedHealth Group Incorporated, its common shares were delisted, and its outstanding debt securities were satisfied and discharged.

The Ontario Securities Commission, acting as principal regulator, granted the requested exemptive relief.